Can stock pickers fight the rise of passive investors? - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Can stock pickers fight the rise of passive investors?

Active fund managers must prove their strategies are worth the cost

“Don’t look for the needle in the haystack. Just buy the haystack,” wrote John Bogle, the late founder of investment firm Vanguard. His quip is now conventional wisdom. America’s passively managed mutual funds and exchange traded funds — which mimic overall market indices — ended last year with more assets than active ones, following years of strong inflows.

Though many still tout their stock and bond picking credentials, active fund managers only rarely generate alpha (or market-beating returns). In the long term the index tends to win, substantiating Bogle’s advice. So, why risk money hoping to unearth the next Google or Amazon when it is both safer and more lucrative to be invested in everything?

That is the question active fund managers fear too many investors are now asking themselves. With the expansion of mutual index and ETF products — covering an array of assets and geographies — shifting cash into diversified trackers is simple. Investment apps allow it to be done with the flick of a finger. For households seeking to earn more from their savings, the growth of these low-cost investment vehicles is an unalloyed good.

Seeking out star or dud stocks is a costlier, more research-intensive exercise, and necessitates a higher fee-based business model. Poor long-term performance and the allure of cheaper passive strategies — which account for 40 per cent of the $45tn worldwide fund assets tracked by Morningstar, up from 14 per cent in 2008 — have eroded active managers’ inflows. Many are cutting costs and restructuring. In its annual results this week, Edinburgh-based Abrdn committed to axing 500 jobs amid large outflows.

The industry and some economists worry that the continued flow of money into buy and hold funds could harm financial markets. Beyond a certain threshold, they argue, a lack of active traders engaged in weeding out over- or underpriced companies could lead to a greater misallocation of investors’ cash.

For now this is just a theoretical concern. In practice, active managers still dominate the global industry. Finding alpha may be hard, particularly when markets are dominated by a few stocks, but opportunities have not suddenly disappeared. And big institutional investors, such as pension funds, still want to put their cash piles to work. Indeed, there remains plenty of interest in market-beating trades. For measure, hedge funds — which deploy higher-risk active strategies for accredited investors — currently outnumber Burger King outlets across the globe.

This is a cut-throat industry. Active funds are competing with hard-to-beat passive strategies, and they are engaged in a zero-sum game with other active players. For each punt, there is a loser taking the other side of the bet. According to Morningstar, in the year to June 2023, 27 per cent of actively managed global large-cap equity funds beat the equivalent passive fund. Over a 15-year timeframe, only 3 per cent have. Active traders can hardly blame investors for switching to index strategies. To survive, they must prove they can actually make money.

Slashing fees, by cutting business costs, is one option to boost the odds of making market-beating returns. Some funds have also found greater chances of beating benchmarks in bond markets and more niche corners of the stock market. Others, like Citadel or DE Shaw, have hired the brightest quant minds or tried deploying tech — from AI to high-frequency trading — to find alpha. Today’s economic uncertainty and the potential for higher-for-longer interest rates should create the volatility that hawk-eyed traders can thrive on.

Yet investors are unlikely to diverge from Bogle’s safe and sound advice without a good reason. That means if the stock pickers are to survive and thrive, they will have to work even harder to offer them one.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
13小时前

Rivian向大型汽车制造商推介软件合作

Rivian首席执行官表示,如果没有更好的软件,传统车企不可能维持其市场份额。

Mythos网络安全风波,预示AI将进入稀缺经济时代

随着前沿模型不断进化,谁能拿到这项技术,可能会变得至关重要。

日本医生警告:伊朗战争将威胁医疗物资供应

首相高市早苗下令释放手套储备,全亚洲忧虑加剧

特朗普能否将鲍威尔从美联储主席之位拉下马?

特朗普表示,如果他提名的继任者沃什在5月15日前未获确认,他将寻求解雇现任主席鲍威尔。

北约与欧盟就防务支出爆发“地盘之争”

这场争议的核心在于,欧盟资金是否应用于采购美国武器。
设置字号×
最小
较小
默认
较大
最大
分享×